N-Acetyl-L Cysteine
Natural health product licensed in Canada
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80041499
- Status
- Active licence
- Licence date
- 8 April 2013
- Revision date
- Not provided
- Form
- Capsule, enrobage gélatine
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Amidon de riz, Stéarate de magnésium, Eau purifiée, Carbohydrate gum
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
| Adultes | Not specified | 1 Capsule | minimum: 2 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Antioxidant for the maintenance of good health. Helps to support immune function in adults over 65, those suffering from chronic degenerative diseases. Helps to relieve symptoms of chronic bronchitis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a physician prior to use if you are taking nitroglycerin. Do not use if you have acetylcysteine allergy, or if you are pregnant or breastfeeding. Consult a physician prior to use if you are taking antibiotics. Consult a physician if you have cystinuria.
Source
Official Health Canada record, licence 80041499
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.